Literature DB >> 17470208

pH 48 h after onset of extracorporeal membrane oxygenation is an independent predictor of survival in patients with respiratory failure.

Filip R Rega1, Veerle Evrard, Hilde Bollen, Geert Peeters, Leen Vercaemst, Bart Meuris, Paul Herijgers, Paul Sergeant, Greet Hermans, Dirk Vlasselaers, Bart Meyns.   

Abstract

Extracorporeal membrane oxygenation (ECMO) is a life-saving procedure in patients with severe respiratory failure, unresponsive to conventional therapy. We reviewed our series of 70 ECMO runs (April 1997 to December 2005) in patients with respiratory distress, refractory to standard ventilation. Survival at 90 days was 42.7%. Besides age, we found no statistical significant difference in patient demographics or preoperative patient data between survivors and nonsurvivors. Univariate analyses indicated that pH values at 24 and 48 h after onset of ECMO were significantly higher in survivors. In multivariate analysis, age and pH at 48 h remained independent predictors of survival. ECMO in respiratory failure saves lives. No other demographic or preoperative, patient-related parameter than age was identified as predictor of survival. Although there was no difference in pH at onset of ECMO, blood gas analysis at 48 h revealed pH as an independent predictor of survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470208     DOI: 10.1111/j.1525-1594.2007.00396.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  2 in total

1.  Extracorporeal membrane oxygenation for respiratory failure: comparison of venovenous versus venoarterial bypass.

Authors:  Kiyohiro Oshima; Fumio Kunimoto; Hiroshi Hinohara; Makio Ohkawa; Norikatsu Mita; Yukio Tajima; Shigeru Saito
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

Review 2.  Extracorporeal gas exchange for acute respiratory failure in adult patients: a systematic review.

Authors:  Matthieu Schmidt; Carol Hodgson; Alain Combes
Journal:  Crit Care       Date:  2015-03-16       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.